BioSpace News Archive

Celprogen Inc., a global leader in the Stem Cell Research and Therapeutics industry for stem cell research since 2002, today announced that they have been awarded the ISO 9001-2015 Certification; the internationally recognized standards to ensures that our products and services meet the needs of our global clients through an effective quality management system.

Stealth BioTherapeutics (NASDAQ: MITO), today announced that Reenie McCarthy , CEO, will present at the 40 th Annual Cowen Health Care Conference in Boston, MA on Wednesday, March 4.

Covetrus to Present at the Raymond James 41st Annual Institutional Investor Conference

Direct Relief has committed an initial $2 million in emergency funding to support the fight against novel coronavirus in the U.S. as national health officials warn of its expected spread.

ESSA Pharma Inc. is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on February 27, 2020 in Vancouver, British Columbia, Canada.

DNA Script today announced the presentation of new data in support of the company’s innovative enzymatic DNA synthesis (EDS) technology

Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR), in particular against rare or resistant cancers, today announces that the Company will present first preclinical results on OX401, its next-generation PARP inhibitor (PARPi), during a poster session at the ESMO-TAT1 Congress 2020

The $1,000,000 raised from Macy’s Thanks for Sharing promotion will be released to 35 agencies in support of ETAF’s two priorities for 2020: support to women, and prevention for young people [27-February-2020] LOS ANGELES , Feb. 27, 2020 /PRNewswire/ -- The Elizabeth Taylor AIDS Foundation (ETAF) announces grant awards to 35 agencies in partnership with Macy’s, as a

Medscape Education, the leading destination for continuous professional development, is launching a new program designed to support health care professionals (HCPs) in better identifying the risks and benefits of opioid therapy.

Direct Relief, BD and the National Association of Free & Charitable Clinics announced $125,000 in funding for five clinics through the Continuity in Care Grant Program, a three-year initiative, now in its final year, to help NAFC member organizations sustain and expand diabetes care in medically underserved areas.